Regulatory T cells suppress sickness behaviour development without altering liver injury in cholestatic mice

Journal of Hepatology

Volumn 56, Issue 3, 2012, Pages 626-631

  Nguyen, Kimchi ^a   D'Mello, Charlotte ^a   Le, Tai ^a   Urbanski, Stefan ^a   Swain, Mark G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cytokine; Endothelium; Fatigue; IL 6; Liver brain axis; Symptom

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; SODIUM CHLORIDE; STAT3 PROTEIN;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BILE DUCT LIGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DISEASE SEVERITY; ENDOTHELIUM CELL; HIPPOCAMPUS; ILLNESS BEHAVIOR; IMMOBILIZATION; KNOCKOUT MOUSE; LIVER INJURY; MALE; MONOCYTE; MOUSE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T CELL DEPLETION; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHOLESTASIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; ILLNESS BEHAVIOR; INTERLEUKIN-6; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY;

EID: 84857360717     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.09.014     Document Type: Article

References (53)

1. G. Abbas, R.A. Jorgensen, and K.D. Lindor Fatigue in primary biliary cirrhosis Nat Rev Gastroenterol Hepatol 7 2010 313 319
2. N. Al-Harthy, T. Kumagi, C. Coltescu, and G.M. Hirschfield The specificity of fatigue in primary biliary cirrhosis: evaluation of a large clinic practice Hepatology 52 2010 562 570
3. M.A. Babatin, F.M. Sanai, and M.G. Swain Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy Aliment Pharmacol Ther 24 2006 813 820
4. M.H. Bemelmans, D.J. Gouma, J.W. Greve, and W.A. Buurman Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice Hepatology 15 1992 1132 1136
5. E. Bjornsson, M. Simren, R. Olsson, and R.W. Chapman Fatigue in patients with primary sclerosing cholangitis Scand J Gastroenterol 39 2004 961 968
6. J.I. Bleier, S.C. Katz, U.I. Chaudhry, V.G. Pillarisetty, T.P. Kingham 3rd, and A.B. Shah Biliary obstruction selectively expands and activates liver myeloid dendritic cells J Immunol 176 2006 7189 7195
7. R.M. Bluthe, B. Michaud, V. Poli, and R. Dantzer Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice Physiol Behav 70 2000 367 373
8. L. Bolden, and M.N. Wicks Predictors of mental health, subjective burden, and rewards in family caregivers of patients with chronic liver disease Arch Psychiatr Nurs 24 2006 89 103
9. J.H. Buckner Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases Nat Rev Immunol 10 2010 849 859
10. K.W. Burak, T. Le, and M.G. Swain Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats Gastroenterology 122 2002 681 688
11. K. Cauch-Dudek, S. Abbey, D.E. Stewart, and E.J. Heathcote Fatigue in primary biliary cirrhosis Gut 43 1998 705 710
12. A.J. Cleare, C. Messa, E.A. Rabiner, and P.M. Grasby Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635 Biol Psychiatry 57 2005 239 246
13. B.N. Cronstein Interleukin-6 - a key mediator of systemic and local symptoms in rheumatoid arthritis Bull NYU Hosp Jt Dis 65 2007 S11 S15
14. C. D'Mello, T. Le, and M.G. Swain Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation J Neurosci 29 2009 2089 2102
15. R. Dantzer, and K.W. Kelley Twenty years of research on cytokine-induced sickness behavior Brain Behav Immun 21 2007 153 160
16. R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, and K.W. Kelley From inflammation to sickness and depression: when the immune system subjugates the brain Nat Rev Neurosci 9 2008 46 56
17. J.E. Everhart, and C.E. Ruhl Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas Gastroenterology 136 2009 1134 1144
18. R.P. Gaykema, and L.E. Goehler Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: Brain substrates for fatigue? Brain Behav Immun 25 2010 443 460
19. T. Hosoi, Y. Okuma, T. Kawagishi, X. Qi, T. Matsuda, and Y. Nomura Bacterial endotoxin induces STAT3 activation in the mouse brain Brain Res 1023 2004 48 53
20. D.R. Johnson, J.C. O'Connor, R. Dantzer, and G.G. Freund Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness Proc Natl Acad Sci USA 102 2005 15184 15189
21. D.E. Jones, A. Al-Rifai, J. Frith, I. Patanwala, and J.L. Newton The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: results of a 9 year follow-up J Hepatol 53 2010 911 917
22. F. Kimura, M. Miyazaki, T. Suwa, T. Sugiura, T. Shinoda, and H. Itoh Serum interleukin-6 levels in patients with biliary obstruction Hepatogastroenterology 46 1999 1613 1617
23. J. Licinio, and M.L. Wong Pathways and mechanisms for cytokine signaling of the central nervous system J Clin Invest 100 1997 2941 2947
24. Y.S. Lim, and W.R. Kim The global impact of hepatic fibrosis and end-stage liver disease Clin Liver Dis 12 2008 733 746 vii
25. O.M. Martinez, J.C. Villanueva, M.E. Gershwin, and S.M. Krams Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis Hepatology 21 1995 113 119
26. C. McDonald, J. Newton, H.M. Lai, S.N. Baker, and D.E. Jones Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms J Hepatol 53 2010 1095 1100
27. P.M. Menon, H.A. Nasrallah, R.R. Reeves, and J.A. Ali Hippocampal dysfunction in Gulf War Syndrome. A proton MR spectroscopy study Brain Res 1009 2004 189 194
28. R. Mingam, A. Moranis, R.M. Bluthe, V. De Smedt-Peyrusse, K.W. Kelley, and P. Guesnet Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice Eur J Neurosci 28 2008 1877 1886
29. T. Nagano, K. Yamamoto, S. Matsumoto, R. Okamoto, M. Tagashira, and N. Ibuki Cytokine profile in the liver of primary biliary cirrhosis J Clin Immunol 19 1999 422 427
30. J.L. Newton, N. Bhala, J. Burt, and D.E. Jones Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure J Hepatol 44 2006 776 783
31. H. Nguyen, H. Wang, T. Le, W. Ho, K.A. Sharkey, and M.G. Swain Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats Neurogastroenterol Motil 20 2008 228 235
32. Y. Ohsugi Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases Biol Pharm Bull 30 2007 2001 2006
33. L. Peyrin-Biroulet Anti-TNF therapy in inflammatory bowel diseases: a huge review Minerva Gastroenterol Dietol 56 2010 233 243
34. T. Pusl, and U. Beuers Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy Clin Rev Allergy Immunol 28 2005 147 157
35. J.L. Riley, C.H. June, and B.R. Blazar Human T regulatory cell therapy: take a billion or so and call me in the morning Immunity 30 2009 656 665
36. C. Rummel, W. Inoue, C. Sachot, S. Poole, T. Hubschle, and G.N. Luheshi Selective contribution of interleukin-6 and leptin to brain inflammatory signals induced by systemic LPS injection in mice J Comp Neurol 511 2008 373 395
37. C. Rummel, C. Sachot, S. Poole, and G.N. Luheshi Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain Am J Physiol Regul Integr Comp Physiol 291 2006 R1316 R1326
38. S. Sakaguchi, M. Miyara, C.M. Costantino, and D.A. Hafler FOXP3+ regulatory T cells in the human immune system Nat Rev Immunol 10 2010 490 500
39. M.E. Sewnath, T. van der Poll, C.J. van Noorden, F.J. ten Kate, and D.J. Gouma Cholestatic interleukin-6-deficient mice succumb to endotoxin-induced liver injury and pulmonary inflammation Am J Respir Crit Care Med 169 2004 413 420
40. M.G. Silveira, and K.D. Lindor Clinical features and management of primary sclerosing cholangitis World J Gastroenterol 14 2008 3338 3349
41. D.K. Sojka, Y.H. Huang, and D.J. Fowell Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target Immunology 124 2008 13 22
42. M.G. Swain Fatigue in liver disease: pathophysiology and clinical management Can J Gastroenterol 20 2006 181 188
43. M.G. Swain, and T. Le Chronic cholestasis in rats induces anhedonia and a loss of social interest Hepatology 28 1998 6 10
44. M.G. Swain, and M. Maric Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment Hepatology 25 1997 291 294
45. J.J. Theal, M.N. Toosi, L. Girlan, R.J. Heslegrave, P.M. Huet, and K.W. Burak A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue Hepatology 41 2005 1305 1312
46. M.M. Tiemessen, A.L. Jagger, H.G. Evans, M.J. van Herwijnen, S. John, and L.S. Taams CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages Proc Natl Acad Sci U S A 104 2007 19446 19451
47. D.A. Vignali, L.W. Collison, and C.J. Workman How regulatory T cells work Nat Rev Immunol 8 2008 523 532
48. P. Wintermeyer, C.W. Cheng, S. Gehring, B.L. Hoffman, M. Holub, and L. Brossay Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage Gastroenterology 136 2009 1048 1059
49. B.S. Wung, C.W. Ni, and D.L. Wang ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells J Biomed Sci 12 2005 91 101
50. M. Yamashiki, Y. Kosaka, A. Nishimura, S. Watanabe, M. Nomoto, and F. Ichida Analysis of serum cytokine levels in primary biliary cirrhosis patients and healthy adults J Clin Lab Anal 12 1998 77 82
51. Y. Yamawaki, H. Kimura, T. Hosoi, and K. Ozawa MyD88 plays a key role in LPS-induced Stat3 activation in the hypothalamus Am J Physiol Regul Integr Comp Physiol 298 2010 R403 410
52. Y. Zhen, J. Zheng, and Y. Zhao Regulatory CD4+CD25+ T cells and macrophages: communication between two regulators of effector T cells Inflamm Res 57 2008 564 570
53. M.H. Zheng, D.N. Gu, M. Braddock, A.J. Leishman, C. Jin, and J.S. Wen CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases Expert Opin Ther Targets 12 2008 313 326